Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P581: Complementary and alternative therapies for inflammatory bowel disease

ECCO '19 Copenhagen

Year: 2019
Authors:

A. M. Fennessy*1, C. Hanna1, N. Breslin1, D. Mc Namara1,2, S. Anwar1, A. O'Connor1,2, B. M. Ryan1,2

1Tallaght University Hospital, Department of Gastroenterology, Dublin 24, Ireland, 2Trinity College Dublin, School of Medicine, Dublin 2, Ireland

P582: Effectiveness and nephrotoxicity of long-term tacrolimus administration in patients with ulcerative colitis

ECCO '19 Copenhagen

Year: 2019
Authors:

K. Haga*1, T. Shibuya1, K. Okahara1, M. Kamei1, M. Takahashi1, O. Nomura1, D. Ishikawa1, N. Sakamoto1, T. Osada2, A. Nagahara1

1Juntendo University School of Medicine, Department of Gastroenterology, Tokyo, Japan, 2Juntendo University Urayasu Hospital, Department of Gastroenterology, Urayasu, Japan

P583: Outcome of treat to target strategy in paediatric patients with Crohn’s disease and ulcerative colitis on adalimumab

ECCO '19 Copenhagen

Year: 2019
Authors:

D. Yerlioglu*1, L. Cococcioni1, A. ElZein1, S. Chadokufa1, R. Buckingham1, S. Sider1, N. Shah1, A. Ocholi1, O. Borrelli1, F. Kiparissi1

1Great Ormond Street Hospital, Gastroenterology, London, UK

P584: Combining faecal calprotectin and sigmoidoscopy can predict mucosal healing in paediatric ulcerative colitis

ECCO '19 Copenhagen

Year: 2019
Authors:

S. Park1, Y. Kang1, H. Koh1, S. Kim*1

1Severance Children's Hospital, Department of pediatrics, Seoul, South Korea

P585: Efficacy of iDose dashboard forecast for individualising Infliximab therapy: an Indian experience

ECCO '19 Copenhagen

Year: 2019
Authors:

M. Dave1, A. Dherai1, D. Desai*2, D. Mould3, T. Ashavaid1

1P D Hinduja Hospital, Biochemistry, Mumbai, India, 2P D Hinduja Hospital, Gastroenterology, Mumbai, India, 3Projection Research, Phoenixville, PA. 19460, USA

P586: Comparative effectiveness of vedolizumab and ustekinumab as induction therapy in anti-TNF refractory Crohn’s disease: a multi-centre retrospective cohort study

ECCO '19 Copenhagen

Year: 2019
Authors:

T. Townsend*1, V. Razanskaite2, S. Michail1, J. Morgan1, M. Davies1, D. Storey1, C. Watters3, D. Penman3, M. Swaminathan4, J. Sabine3, A. Chapman2, A. Vyas2, I. Reilly4, P. Flanagan3, K. Bodger2, S. Subramanian1

1Royal Liverpool University Hospital, Gastroenterology, Liverpool, UK, 2Aintree University Hospital, Gastroenterology, Liverpool, UK, 3Arrowe Park Hospital, Gastroenterology, Upton, UK, 4Countess of Chester Hospital, Gastroenterology, Chester, UK

P587: Quality of care indicators in inflammatory bowel disease: local pilot study

ECCO '19 Copenhagen

Year: 2019
Authors:

R. Sarraj*1, F. Bravo1, M. Maude1, A. Macpherson1, P. Juillerat1

1Inselspital / University hospital Bern, Bern, Switzerland

P588: Tacrolimus suppositories: a safe and effective treatment for treatment-refractory proctitis

ECCO '19 Copenhagen

Year: 2019
Authors:

R. Smith*1, H. Weekes2, L. Morgan2, M. Parkes1, J. C. Lee1

1University of Cambridge, Department of Medicine, Cambridge, UK, 2Addenbrooke's Hospital, Pharmacy, Cambridge, UK

P589: A population pharmacokinetic model to improve mucosal healing upon golimumab induction therapy in patients with ulcerative colitis

ECCO '19 Copenhagen

Year: 2019
Authors:

W. Kantasiripitak1, E. Dreesen*1, I. Detrez1, S. Stefanović2, D. Drobne2, S. Vermeire3,4, M. Ferrante3,4, A. Gils1

1University of Leuven, Department of Pharmaceutical and Pharmacological Sciences, Leuven, Belgium, 2University Medical Centre Ljubljana, Department of Gastroenterology and Hepatology, Ljubljana, Slovenia, 3University Hospitals Leuven, Department of Gastroenterology and Hepatology, Leuven, Belgium, 4University of Leuven, Department of Chronic Diseases, Metabolism and Ageing, Leuven, Belgium

P591: Low donor microbial engraftment after combined endoscopic and oral faecal microbiota transplant (FMT) in patients with antibiotic dependent pouchitis

ECCO '19 Copenhagen

Year: 2019
Authors:

H. Herfarth*1, E. L. Barnes1, M. D. Long1, K. L. Isaacs1, T. Leith2, M. Silverstein3, Y. Gerardin3, Z. Kassam3

1University of North Carolina, Medicine, Chapel Hill, USA, 2OpenBiome, Somerville, MA, USA, 3Finch, Somerville, MA, USA

P592: Towards a Food Pharmacy: increased dietary quality reduces CRP and improves quality of life in IBD patients in remission

ECCO '19 Copenhagen

Year: 2019
Authors:

I. Molendijk*1, J. E. Martens1, E. van Lingen1, S. van der Marel1, M. E. van Veen-Lievaart2, A. E. van der Meulen1, M. C. Barnhoorn1, A. M. Ernst-Stegeman3, J. Maljaars1

1Leiden University Medical Center, Gastroenterology and Hepatology, Leiden, The Netherlands, 2Leiden University Medical Center, Dietetics, Leiden, The Netherlands, 3Voeding Leeft, Amsterdam, The Netherlands

P593: A national database study on colectomy and colorectal cancer in ulcerative colitis: what is the role of appendectomy?

ECCO '19 Copenhagen

Year: 2019
Authors:

M. E. Stellingwerf*1, W. A. Bemelman1, G. R. D'Haens2, C. Y. Ponsioen2, C. J. Buskens1

1Amsterdam UMC, Department of Surgery, Amsterdam, The Netherlands, 2Amsterdam UMC, Department of Gastroenterology and Hepatology, Amsterdam, The Netherlands

P594: Predictors of non-response to repeated faecal microbiota transplantation in patients with therapy refractory ulcerative colitis

ECCO '19 Copenhagen

Year: 2019
Authors:

A. Blesl*1, F. Rainer1, P. Wurm1, M. Durdevic1, W. Petritsch1, H. Wenzl1, F. Baumann-Durchschein1, A. Posch1, A. Streit1, G. Gorkiewicz1, H-P. Gröchenig2, P. Kump1, C. Högenauer1

1Medical University of Graz, Graz, Austria, 2Barmherzige Brüder St. Veit/Glan, St. Veit, Austria

P595: Early medical therapy and risk of subsequent perianal fistula development among paediatric patients with Crohn’s disease

ECCO '19 Copenhagen

Year: 2019
Authors:

J. Adler*1,2, C. C. Lin3, S. Gadepalli2,4, K. Dombkowski2

1University of Michigan, Pediatric Gastroenterology, Ann Arbor, USA, 2University of Michigan, Child Health Evaluation and Research (CHEAR) Center, Ann Arbor, USA, 3University of Michigan, Health Services Research Program, Department of Neurology, Ann Arbor, USA, 4University of Michigan, Pediatric Surgery, Ann Arbor, USA

P596: An ongoing safety registry to identify rare and severe complications in children with paediatric-onset IBD

ECCO '19 Copenhagen

Year: 2019
Authors:

M. A. Aardoom*1, P. Kemos2, F. Ruemmele3, N. Croft2, L. de Ridder1, PIBD SETQuality consortium and PIBDnet1

1Erasmus Medical Center - Sophia Children's Hospital, Paediatric gastroenterology, Rotterdam, The Netherlands, 2Centre for Immunobiology, Blizard Institute, Barts and the London School of Medicine, Queen Mary University of London, Paediatric gastroenterology, London, UK, 3Université Paris Descartes, Sorbonne Paris Cité, APHP, Hôpital Necker Enfants Malades, Paediatric gastroenterology, Paris, France

P597: Optimising therapeutic drug monitoring of adalimumab with dried blood samples in IBD patients: an interim analysis

ECCO '19 Copenhagen

Year: 2019
Authors:

S. Berends*1,2, K. Bloem3, R. Talwar1, A. De Vries3, T. Schaap3, A. Strik2, M. Löwenberg2, G. D'Haens2, R. Mathôt1

1Amsterdam UMC - location AMC, Hospital Pharmacy, Amsterdam, The Netherlands, 2Amsterdam UMC - location AMC, Gastroenterology and Hepatology, Amsterdam, The Netherlands, 3Sanquin Diagnostic Services, Biologics Lab, Bioanalysis, Amsterdam, The Netherlands

P598: Safety and effectiveness of adalimumab treatment in 1523 patients with ulcerative colitis: Results from a prospective, multi-centre, observational study

ECCO '19 Copenhagen

Year: 2019
Authors:

H. Ogata*1, T. Hagiwara2, Y. Ito2, T. Kawaberi2, M. Kobayashi2, T. Hibi3

1Center for Diagnostic and Therapeutic Endoscopy, School of Medicine, Keio University, Tokyo, Japan, 2AbbVie GK, Tokyo, Japan, 3Center for Advanced IBD Research and Treatment, Kitasato Institute Hospital, Kitasato University, Tokyo, Japan

P599: Development of an inflammatory bowel disease-specific nutrition screening tool (IBD-NST)

ECCO '19 Copenhagen

Year: 2019
Authors:

C. Wall*1, B. Wilson1, J. Sanderson2, M. Lomer1,3

1King's College London, Department of Nutritional Sciences, London, UK, 2Guy's and St Thomas' NHS Foundation Trust, Department of Gastroenterology, London, UK, 3Guy's and St Thomas' NHS Foundation Trust, London, UK

P600: Ustekinumab for Crohn’s disease: a nationwide real-life observational cohort study from Finland

ECCO '19 Copenhagen

Year: 2019
Authors:

A. Eberl*1, T. Hallinen2, C-G. af Björkesten3, M. Heikkinen4, E. Hirsi5, M. Kellokumpu6, I. Koskinen7, V. Moilanen8, C. Nielsen9, H. Nuutinen10, U-M. Suhonen11, K. Utriainen12, I. Vihriälä13, E. Soini2, C. Wennerström14, R. Nissinen15, A. Borsi16, M. Koivunen15, J. Tillonen17, T. Sipponen1

1Helsinki University Hospital, Clinic of Gastroenterology, Helsinki, Finland, 2Esior Oy, Kuopio, Finland, 3Helsinki University Hospital/Jorvi Hospital, Department of Gastroenterology, Espoo, Finland, 4Kuopio University Hospital, Department of Internal Medicine, Kuopio, Finland, 5South Karelia Central Hospital, Department of Internal Medicine, Lappeenranta, Finland, 6Lapland Central Hospital, Department of Internal Medicine, Rovaniemi, Finland, 7Central Hospital of Central Finland, Department of Internal Medicine, Jyväskylä, Finland, 8Satakunta Central Hospital, Department of Internal Medicine, Pori, Finland, 9Vaasa Central Hospital, Department of Internal Medicine, Vaasa, Finland, 10Turku University Hospital, Division of Gastroenterology, Department of Medicine, Turku, Finland, 11Kainuu Central Hospital, Department of Internal Medicine, Kajaani, Finland, 12Turku University Hospital/Salo hospital, Division of Gastroenterology, Department of Medicine, Salo, Finland, 13Central Ostrobothnia Central Hospital, Department of Internal Medicine, Kokkola, Finland, 14Janssen-Cilag AB, Medical Affairs, Solna, Sweden, 15Janssen-Cilag Oy, Medical Affairs, Espoo, Finland, 16Janssen-Cilag Limited, EPC - HEMAR, Buckinghamshire, UK, 17Department of Internal Medicine, Päijät-Häme Central Hospital, Lahti, Finland

P601: Differential cytokine profiles and drop of faecal calprotectin for prediction of primary response to infliximab induction therapy in Crohn’s disease

ECCO '19 Copenhagen

Year: 2019
Authors:

B. Mateos1, E. Sáez1,2, I. Moret1,3, D. Hervás4, L. Tortosa1,3, E. Cerrillo2,3, M. Iborra2,3, M. García2, P. Nos1,2,3, B. Beltrán1,2,3

1IIS Hospital La Fe, Gastroenterology, Valencia, Spain, 2Hospital Universitari i Politècnic La Fe, Gastroenterology, Valencia, Spain, 3CIBEREHD, Madrid, Spain, 4IIS Hospital La Fe, Biostatistics, Valencia, Spain